Top Markets
Coin of the day
Medigen Biotechnology Corp. Medigen Biotechnology Corp.

Medigen Biotechnology Corp.

3176
株式のランク #19061
Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated... Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated to inventing therapies for liver diseases and various forms of cancer. Its product portfolio includes advanced cell therapies like MAGICELL-NK, which leverages natural killer cells, and MAGICELL-GDT, a T-cell-based treatment. A significant pipeline asset for Medigen is OBP-301. This therapeutic has completed Phase I clinical trials for combination therapy in esophageal cancer in Japan. It is currently being evaluated in ongoing Phase I trials in Japan, combining it with immune checkpoint inhibitors (ICIs) for esophageal cancer, and has advanced to Phase II studies in the United States, investigating its use with ICIs for both esophageal and gastric cancer. Established in 1999, Medigen Biotechnology Corp. maintains its corporate headquarters in Taipei, Taiwan.
株価
$1.27
時価総額
$176.31M
変化(1日)
5.57%
変化(1年)
29.36%
TW
取引 Medigen Biotechnology Corp. (3176)

カテゴリー

Medigen Biotechnology Corp.(3176)の株価履歴
終値の最高値: $1.12 (2026-08-01)

終値の最安値: $1.26 (2007-12-01)
Medigen Biotechnology Corp. の株価履歴(2007 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 0.89%
2025 -0.53%
2024 -32.95%
2023 27.93%
2022 -41.27%
2021 -4.41%
2020 1.18%
2019 52.77%
2018 15.52%
2017 -52.31%
2016 -10.15%
2015 -44.93%
2014 -20.99%
2013 7.34%
2012 409.30%
2011 131.95%
2010 8.02%
2009 42.20%
2008 -74.41%
2007 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$548.98 41.79%
US
$1.04K 46.43%
NL
$149.93 506.27%
US
$121.62 -12.98%
AU
$763.69 6.14%
CH